BE905318A - PHARMACEUTICAL COMPOSITION FOR INHIBITION OF THE SECRETION OF PARATHYROIDIAN HORMONE. - Google Patents
PHARMACEUTICAL COMPOSITION FOR INHIBITION OF THE SECRETION OF PARATHYROIDIAN HORMONE.Info
- Publication number
- BE905318A BE905318A BE0/217072A BE217072A BE905318A BE 905318 A BE905318 A BE 905318A BE 0/217072 A BE0/217072 A BE 0/217072A BE 217072 A BE217072 A BE 217072A BE 905318 A BE905318 A BE 905318A
- Authority
- BE
- Belgium
- Prior art keywords
- hormone
- parathyroidian
- secretion
- inhibition
- pharmaceutical composition
- Prior art date
Links
- 229940088597 hormone Drugs 0.000 title 1
- 239000005556 hormone Substances 0.000 title 1
- 230000005764 inhibitory process Effects 0.000 title 1
- 239000008194 pharmaceutical composition Substances 0.000 title 1
- 230000028327 secretion Effects 0.000 title 1
- 208000006386 Bone Resorption Diseases 0.000 abstract 2
- 102000003982 Parathyroid hormone Human genes 0.000 abstract 2
- 108090000445 Parathyroid hormone Proteins 0.000 abstract 2
- 230000024279 bone resorption Effects 0.000 abstract 2
- 239000000199 parathyroid hormone Substances 0.000 abstract 2
- 229960001319 parathyroid hormone Drugs 0.000 abstract 2
- 208000013038 Hypocalcemia Diseases 0.000 abstract 1
- 239000002253 acid Substances 0.000 abstract 1
- 238000005115 demineralization Methods 0.000 abstract 1
- 230000002328 demineralizing effect Effects 0.000 abstract 1
- 230000000705 hypocalcaemia Effects 0.000 abstract 1
- 238000000338 in vitro Methods 0.000 abstract 1
- 238000001727 in vivo Methods 0.000 abstract 1
- 231100000252 nontoxic Toxicity 0.000 abstract 1
- 230000003000 nontoxic effect Effects 0.000 abstract 1
- 230000001575 pathological effect Effects 0.000 abstract 1
- 210000004872 soft tissue Anatomy 0.000 abstract 1
- 231100000331 toxic Toxicity 0.000 abstract 1
- 230000002588 toxic effect Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/42—Phosphorus; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
- A61K31/675—Phosphorus compounds having nitrogen as a ring hetero atom, e.g. pyridoxal phosphate
Abstract
L'hormone parathyroidienne, lorsqu'elle est synthétisée en excès, provoque une résorption osseuse et une déminéralisation pathologiques, et aboutit à l'hypocalcémie, qui produit des effets toxiques dans les tissus mous. Un dérivé de l'acide peroxodiphosphorique, non toxique, soluble dans l'eau, pharmaceutiquement acceptable, administré par voie orale ou par voie générale, inhibe in vitro et in vivo chez des animaux à sang chaud la résorption osseuse provoquée par l'hormone parathyroidienne.Parathyroid hormone, when synthesized in excess, causes bone resorption and pathological demineralization, and results in hypocalcemia, which produces toxic effects in soft tissue. A non-toxic, water-soluble, pharmaceutically acceptable, peroxodiphosphoric acid derivative, administered orally or generally, inhibits bone resorption caused by parathyroid hormone in vitro and in vivo .
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US76839485A | 1985-08-22 | 1985-08-22 | |
| US85191486A | 1986-04-14 | 1986-04-14 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BE905318A true BE905318A (en) | 1987-02-23 |
Family
ID=27118048
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BE0/217072A BE905318A (en) | 1985-08-22 | 1986-08-22 | PHARMACEUTICAL COMPOSITION FOR INHIBITION OF THE SECRETION OF PARATHYROIDIAN HORMONE. |
Country Status (10)
| Country | Link |
|---|---|
| BE (1) | BE905318A (en) |
| CH (1) | CH669731A5 (en) |
| DE (1) | DE3628190A1 (en) |
| DK (1) | DK164443C (en) |
| FR (1) | FR2586350B1 (en) |
| GB (1) | GB2179255B (en) |
| HK (1) | HK1293A (en) |
| IT (1) | IT1196586B (en) |
| NL (1) | NL8602139A (en) |
| SE (1) | SE468625B (en) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE102007020155A1 (en) | 2007-04-26 | 2008-10-30 | Hein Lehmann Trenn- und Fördertechnik GmbH | Fixing system for flexible screening mats |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4041149A (en) * | 1976-01-12 | 1977-08-09 | Colgate-Palmolive Company | Composition and method of controlling and preventing mouth odor |
| US4430325A (en) * | 1981-12-23 | 1984-02-07 | Colgate-Palmolive Company | Topical treatment of skin lesions |
| DK168191B1 (en) * | 1984-06-27 | 1994-02-28 | Colgate Palmolive Co | Use of peroxydiphosphates for the preparation of pharmaceutical tablets or pharmaceutical aqueous solutions |
| US4689214A (en) * | 1985-04-16 | 1987-08-25 | Colgate-Palmolive Company | Composition to counter breath odor |
| DE3627759A1 (en) * | 1985-08-22 | 1987-03-19 | Colgate Palmolive Co | PHARMACEUTICAL COMPOSITION FOR INACTIVATING BACTERIAL ENDOTOXINS |
-
1986
- 1986-08-18 FR FR868611811A patent/FR2586350B1/en not_active Expired - Lifetime
- 1986-08-19 IT IT48388/86A patent/IT1196586B/en active
- 1986-08-19 SE SE8603485A patent/SE468625B/en not_active IP Right Cessation
- 1986-08-20 DE DE19863628190 patent/DE3628190A1/en not_active Withdrawn
- 1986-08-22 NL NL8602139A patent/NL8602139A/en not_active Application Discontinuation
- 1986-08-22 CH CH3378/86A patent/CH669731A5/de not_active IP Right Cessation
- 1986-08-22 GB GB8620481A patent/GB2179255B/en not_active Expired
- 1986-08-22 BE BE0/217072A patent/BE905318A/en not_active IP Right Cessation
- 1986-08-22 DK DK401986A patent/DK164443C/en not_active IP Right Cessation
-
1993
- 1993-01-14 HK HK12/93A patent/HK1293A/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| GB2179255A (en) | 1987-03-04 |
| IT8648388A0 (en) | 1986-08-19 |
| FR2586350A1 (en) | 1987-02-27 |
| SE468625B (en) | 1993-02-22 |
| DE3628190A1 (en) | 1987-02-26 |
| DK164443B (en) | 1992-06-29 |
| SE8603485D0 (en) | 1986-08-19 |
| IT1196586B (en) | 1988-11-16 |
| FR2586350B1 (en) | 1992-05-15 |
| NL8602139A (en) | 1987-03-16 |
| GB8620481D0 (en) | 1986-10-01 |
| CH669731A5 (en) | 1989-04-14 |
| DK164443C (en) | 1992-11-16 |
| GB2179255B (en) | 1989-10-11 |
| HK1293A (en) | 1993-01-21 |
| DK401986A (en) | 1987-02-23 |
| DK401986D0 (en) | 1986-08-22 |
| SE8603485L (en) | 1987-02-23 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BE1002109A3 (en) | PHARMACEUTICAL COMPOSITION WITH ANALGESIC ACTIVITY. | |
| MA23170A1 (en) | PROCESS FOR THE PREPARATION OF A NEW COMPOUND. | |
| ATE67933T1 (en) | CONTROLLED RELEASE HYDROMORPHONE COMPOSITION. | |
| MX9504034A (en) | Medical administering forms containing tioctic acid, or tioctic acid solid salts having improved release and bioavailability. | |
| RU93058389A (en) | Pharmaceutical compositions comprising S (-) - 2- (4-isobutylphenyl) propionate METHOD FOR ITS PREPARATION, USE OF COMPOSITIONS, METHODS Preparation of the Enantiomers of 2- (4-isobutylphenyl) propionic acid, S (-) - 2- (4 -ISOBUTYLPHENYL) Sodium propionate dihydrate | |
| DE3750145T2 (en) | Controlled release composition of dihydrocodeine. | |
| LU90392I2 (en) | A combination comprising salmeterol optionally in the form of a pharmaceutically acceptable salt including 1-hydroxy-2-naphthoate (xinafoate) and fluticasone propionate | |
| DK1227806T3 (en) | Pharmaceutical preparation containing tolterodine and its use | |
| ES8603870A1 (en) | Derivatives of 2,2'-iminobisethanol. | |
| ES539266A0 (en) | A PROCEDURE FOR THE PREPARATION OF NEW-N-HETEROCICLIL-4-PIPERIDINAMINES. | |
| BG104476A (en) | Therapeutical form for tolterodin with controlled release | |
| IT1246188B (en) | PROCEDURE FOR THE PREPARATION OF PHARMACEUTICAL COMPOSITIONS HAVING INCREASED SPEED OF DISSOLUTION OF THE ACTIVE SUBSTANCE AND COMPOSITIONS OBTAINED. | |
| OA09415A (en) | "Pharmaceutical composition for oral administration based on a derivative of diphosphonic acid". | |
| EP0137543B1 (en) | Use of defibrotide for the preparation of pharmaceutical compositions for the therapeutical treatment of peripheral arteriopathies | |
| SE8704248D0 (en) | MEDICAL USE | |
| MA26608A1 (en) | PROCESS FOR THE PREPARATION OF A PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF HEART FAILURE. | |
| CY1108863T1 (en) | PHARMACEUTICAL PREPARATION OF EXTREMELY INDEPENDENT RELEASE FROM RI | |
| YU27395A (en) | WET GRANULATION OF BISPHOSPHINIC ACID FORMULATION | |
| FR2754177B1 (en) | PHARMACEUTICAL MICROSPHERES OF VALPROIC ACID FOR ORAL ADMINISTRATION | |
| IL90056A0 (en) | Topical pharmaceutical compositions containing 4-quinoline carboxylic acid derivatives | |
| EP0353821A3 (en) | Antipsychotic 3-piperazinyl-benzazole derivatives | |
| EP0269311A3 (en) | Methods of treating bone diseases by administration of a cysteine proteinase inhibitor | |
| NZ332655A (en) | Pharmaceutical compositions containing diclofenac and alkali metal bicarbonates | |
| BE905318A (en) | PHARMACEUTICAL COMPOSITION FOR INHIBITION OF THE SECRETION OF PARATHYROIDIAN HORMONE. | |
| IT8219482A0 (en) | PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF ORAL CAVITY DISEASES. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RE | Patent lapsed |
Owner name: COLGATE-PALMOLIVE CY Effective date: 19930831 |